Suppr超能文献

相似文献

1
Biological response modifier therapy for refractory childhood uveitis.
Br J Ophthalmol. 2007 Oct;91(10):1341-4. doi: 10.1136/bjo.2007.124081. Epub 2007 Jun 7.
2
Retrospective case review of pediatric patients with uveitis treated with infliximab.
Ophthalmology. 2006 Feb;113(2):308-14. doi: 10.1016/j.ophtha.2005.09.037. Epub 2006 Jan 10.
3
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Ophthalmology. 2012 Aug;119(8):1575-81. doi: 10.1016/j.ophtha.2012.02.018. Epub 2012 Apr 21.
4
Use of adalimumab in refractory non-infectious childhood chronic uveitis: efficacy in ocular disease--a case cohort interventional study.
Rheumatology (Oxford). 2012 Dec;51(12):2199-203. doi: 10.1093/rheumatology/kes212. Epub 2012 Aug 25.
5
Treatment of ocular inflammatory disorders with daclizumab.
Ophthalmology. 2003 Apr;110(4):786-9. doi: 10.1016/S0161-6420(02)01932-2.
6
Biologic response modifier therapy for psoriatic ocular inflammatory disease.
Ocul Immunol Inflamm. 2008 May-Jun;16(3):89-93. doi: 10.1080/09273940802023786.
7
Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis.
Ophthalmology. 2006 Oct;113(10):1874-7. doi: 10.1016/j.ophtha.2006.05.016. Epub 2006 Aug 1.
8
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
Ophthalmology. 2006 Dec;113(12):2317-23. doi: 10.1016/j.ophtha.2006.04.038. Epub 2006 Sep 25.
10
Surgery for hypotony in patients with juvenile idiopathic arthritis-associated uveitis.
Ocul Immunol Inflamm. 2007 Jan-Feb;15(1):11-7. doi: 10.1080/09273940601147729.

引用本文的文献

1
Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case series.
Int Ophthalmol. 2024 Sep 10;44(1):376. doi: 10.1007/s10792-024-03289-1.
3
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.
Clin Rheumatol. 2020 Feb;39(2):327-337. doi: 10.1007/s10067-019-04763-3. Epub 2019 Dec 10.
5
Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review.
Drug Des Devel Ther. 2018 Jul 4;12:2005-2016. doi: 10.2147/DDDT.S160431. eCollection 2018.
6
Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.
Ann Rheum Dis. 2018 Aug;77(8):1107-1117. doi: 10.1136/annrheumdis-2018-213131. Epub 2018 Mar 28.
7
Diagnosis and Management of Multiple Sclerosis in Children.
Iran J Child Neurol. 2016 Summer;10(3):13-23.
8
Pars Planitis: Epidemiology, Clinical Characteristics, Management and Visual Prognosis.
J Ophthalmic Vis Res. 2015 Oct-Dec;10(4):469-80. doi: 10.4103/2008-322X.176897.
9
The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.
Paediatr Drugs. 2015 Aug;17(4):283-301. doi: 10.1007/s40272-015-0128-2.
10
Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors.
Am J Ophthalmol. 2015 Jul;160(1):193-200.e1. doi: 10.1016/j.ajo.2015.04.016. Epub 2015 Apr 17.

本文引用的文献

1
Adalimumab in the therapy of uveitis in childhood.
Br J Ophthalmol. 2007 Mar;91(3):319-24. doi: 10.1136/bjo.2006.103721. Epub 2006 Oct 11.
2
Adalimumab therapy for childhood uveitis.
J Pediatr. 2006 Oct;149(4):572-5. doi: 10.1016/j.jpeds.2006.04.058.
3
Favorable response to high-dose infliximab for refractory childhood uveitis.
Ophthalmology. 2006 May;113(5):860-4.e2. doi: 10.1016/j.ophtha.2006.01.005. Epub 2006 Mar 20.
4
Retrospective case review of pediatric patients with uveitis treated with infliximab.
Ophthalmology. 2006 Feb;113(2):308-14. doi: 10.1016/j.ophtha.2005.09.037. Epub 2006 Jan 10.
5
Analysis of pediatric uveitis cases at a tertiary referral center.
Ophthalmology. 2005 Jul;112(7):1287-92. doi: 10.1016/j.ophtha.2005.01.044.
9
Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders.
Ophthalmology. 2003 May;110(5):1061-5. doi: 10.1016/S0161-6420(03)00092-7.
10
Treatment of ocular inflammatory disorders with daclizumab.
Ophthalmology. 2003 Apr;110(4):786-9. doi: 10.1016/S0161-6420(02)01932-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验